雙塔食品(002481.SZ)漲停 間接供貨肯德基植培肉黃金雞塊
格隆匯4月21日丨肯德基中國4月20日宣佈在上海、廣州和深圳三地門店試點開賣植物“人造肉”產品“植培黃金雞塊”,今日A股市場人造肉概念股全線上漲,其中,雙塔食品(002481.SZ)上午臨近午盤收盤時直線拉漲停,報13.65元,暫成交11.1億元,最新總市值170億元。其他人造肉概念股如京糧控股、愛普股份和金字火腿等都有明顯上漲。針對“肯德基4月20日新品植培肉黃金雞塊,是否與公司有直接或間接關係?是否有使用公司豌豆蛋白產品?”的問題,雙塔食品今日上午在互動易平台表示,有間接供貨關係,使用的是公司的豌豆蛋白產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.